![Martin F. Schacker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin F. Schacker
Algemeen Directeur bij Tetragenex Pharmaceuticals, Inc.
Actieve functies van Martin F. Schacker
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Tetragenex Pharmaceuticals, Inc.
![]() Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Algemeen Directeur | 05-02-2010 | - |
Voorzitter | 05-02-2010 | - |
Loopbaan van Martin F. Schacker
Eerdere bekende functies van Martin F. Schacker
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
M.S. Farrell & Co., Inc. | Voorzitter | 02-02-2001 | 02-02-2001 |
President | - | 02-02-2001 | |
D.H. Blair & Co. | Corporate Officer/Principal | 02-12-1991 | 02-12-1991 |
Lehman Brothers Holdings Plc
![]() Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK. | Corporate Officer/Principal | 02-05-1987 | 02-05-1987 |
Opleiding van Martin F. Schacker
Hofstra University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Verenigd Koninkrijk | 2 |
Operationeel
Chairman | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 2 |
Finance | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Tetragenex Pharmaceuticals, Inc.
![]() Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
M.S. Farrell & Co., Inc. | |
D.H. Blair & Co. | |
Lehman Brothers Holdings Plc
![]() Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK. | Finance |
- Beurs
- Insiders
- Martin F. Schacker
- Ervaring